SCHEMBL2490256

SCHEMBL2490256

CCP(CC)c1ccccc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.34
TAAR1 Q96RJ0 3/20 0.33
RECQL P46063 1/20 0.33
GRM2 Q14416 2/20 0.32
NOS3 P29474 2/20 0.32
NOS1 P29475 2/20 0.32
NOS2 P35228 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
NFKB1 P19838 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PLCG1 P19174 1/20 0.31
IDO1 P14902 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
MAPK1 P28482 1/20 0.31
HPGD P15428 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30616094 0.82 TP53 (0.36) ALDH1A1TSHRCYP1A2CYP2D6HPGD
SCHEMBL2912079 0.82 TP53 (0.36) ALDH1A1TSHRCYP1A2CYP2D6HPGD
SCHEMBL7033231 0.76 ANPEP (0.37) ALDH1A1TAAR1GRM2
SCHEMBL4449690 0.75 TP53 (0.32) ALDH1A1CYP1A2CYP2C19HSD17B10MAPK1
Carbon Monoxide SCHEMBL11677050 0.73 MEN1 (0.31) ALDH1A1
SCHEMBL7557905 0.73 ACHE (0.43) ALDH1A1TSHRTAAR1CYP1A2
SCHEMBL18204216 0.72 ALDH1A1 (0.43) ALDH1A1TAAR1PLCG1IDO1MAPK1
SCHEMBL4438970 0.71 CYP3A4 (0.41) ALDH1A1TSHRCYP1A2CYP2D6CYP2C19
SCHEMBL2967314 0.71
SCHEMBL7194415 0.71 ALDH1A1 (0.41) ALDH1A1TSHRTAAR1RECQLCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3762380-B1 PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS BRISTOL MYERS SQUIBB CO (US) 2021-12-15 EP disclosed
EP-2041150-B1 DIPHOSPHINE LIGANDS SOLVIAS AG (CH) 2011-10-26 EP disclosed
US-20100029967-A1 Diphosphine ligands SOLVIAS AG (CH) 2010-02-04 US disclosed
CN-101479284-A Diphosphine ligands SOLVIAS AG (CH) 2009-07-08 CN disclosed
EP-2041150-A1 DIPHOSPHINE LIGANDS Solvias AG (CH) 2009-04-01 EP disclosed
WO-2008000815-A1 DIPHOSPHINE LIGANDS SOLVIAS AG (CH) 2008-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029967-A1 Diphosphine ligands C1S, CHRM1, CCNE1 ALDH1A1 4523/4885TSHR 1269/4885TAAR1 216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.